AVITA Medical, Inc.RCELNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P38
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -1.31% |
| Q3 2025 | -8.10% |
| Q2 2025 | -1.15% |
| Q1 2025 | -0.04% |
| Q4 2024 | -14.15% |
| Q3 2024 | 3.83% |
| Q2 2024 | 10.27% |
| Q1 2024 | 20.24% |
| Q4 2023 | 7.87% |
| Q3 2023 | 3.02% |
| Q2 2023 | 8.99% |
| Q1 2023 | 27.20% |
| Q4 2022 | 11.98% |
| Q3 2022 | -3.59% |
| Q2 2022 | -12.61% |
| Q1 2022 | 25.45% |
| Q4 2021 | 11.13% |
| Q3 2021 | -5.88% |
| Q2 2021 | 3.86% |
| Q1 2021 | 29.57% |
| Q4 2020 | -39.47% |
| Q3 2020 | -21.16% |
| Q2 2020 | -14.51% |
| Q1 2020 | 54.91% |
| Q4 2019 | 11.52% |
| Q3 2019 | 17.01% |
| Q2 2019 | -1.53% |
| Q1 2019 | 64.97% |
| Q4 2018 | -2.54% |
| Q3 2018 | -27.16% |
| Q2 2018 | 97.27% |
| Q1 2018 | 49.08% |
| Q4 2017 | -0.50% |
| Q3 2017 | -22.47% |
| Q2 2017 | 0.60% |
| Q1 2017 | 63.84% |
| Q4 2016 | -5.73% |
| Q3 2016 | -10.11% |
| Q2 2016 | -3.07% |
| Q1 2016 | 40.27% |